Affordable Access

deepdyve-link
Publisher Website

Building on evidence to improve patient care.

Authors
  • Snauwaert, Evelien1
  • VandeWalle, Johan1
  • Nagler, Evi V2, 3
  • Van Biesen, Wim4, 5
  • 1 Department of Paediatric Nephrology, Ghent University Hospital, Ghent, Belgium. , (Belgium)
  • 2 Department of Nephrology, Ghent University Hospital 0K12IA, Ghent, Belgium. , (Belgium)
  • 3 Methods Support Team of European Renal Best Practice (ERBP), Ghent University Hospital, Ghent, Belgium. , (Belgium)
  • 4 Department of Nephrology, Ghent University Hospital 0K12IA, Ghent, Belgium. [email protected] , (Belgium)
  • 5 Methods Support Team of European Renal Best Practice (ERBP), Ghent University Hospital, Ghent, Belgium. [email protected] , (Belgium)
Type
Published Article
Journal
Pediatric Nephrology
Publisher
Springer-Verlag
Publication Date
Dec 01, 2017
Volume
32
Issue
12
Pages
2193–2202
Identifiers
DOI: 10.1007/s00467-016-3554-7
PMID: 27942956
Source
Medline
Keywords
License
Unknown

Abstract

Evidence-based medicine (EBM) is gaining importance in the current paediatric healthcare landscape. Improvement of paediatric health status is its major aim. However, for EBM to be successful, all stakeholders involved should understand what EBM really is, why and how EBM should or should not be practiced, and have the necessary skills to distinguish methodologically sound papers from biased opinion papers, and understand how and why guidelines are different from systematic reviews. Improving patient outcome requires attention to high-quality evidence and understanding of the processes of medical decision-making. Rigorous methodology is the cornerstone of guideline production, but in cases where quality evidence cannot be produced, as is often the case in paediatric nephrology because of low patient numbers, consensus-based guidance may be suitable to assist the practitioner at the bedside, as long as the underlying process is transparent. Most importantly, EBM should support patient involvement in a shared decision-making process. The more consistent and accurately predictable the effect of certain interventions is, clinically relevant to patients rather than affecting surrogate outcomes, and a priority for patients and other stakeholders, the more likely it is that adherence to the guidance provided will improve the outcome of patients.

Report this publication

Statistics

Seen <100 times